Despite a national addiction crisis, opioids remain an appropriate choice for treating severe cancer pain.
"In the midst of all of the difficulty of trying to deal with something this terrible, having that hope in your back pocket is invaluable to my life and to my family." - Brian Smith, on living with multiple myeloma and participating in Moving Mountains for Multiple Myeloma's recent Iceland trek.
Ronald Natale, medical oncologist at Cedars-Sinai Medical Center, discusses treatment options for patients with EGFR-mutated lung cancer.
Be careful where you get your information, said Leonard Gomella, M.D.
While recent advances in hematology are exciting, they open the door to more questions.
The incidence of colorectal and gastric cancers has risen for younger patients, and many of them share ethnic and socioeconomic disparities as well.
After breast cancer, one woman found new purpose and renewed relationships by adopting a special puppy. Now, she fosters others.
Investigators are studying a rare ovarian tumor called sclerosing stromal tumor, a benign tumor that can be misdiagnosed as cancer.
Dr. Regina Hampton discusses key factors contributing to this disparity, and how healthcare systems can address these challenges.
The results of a phase 2 study looking at Padcev and Keytruda combination therapy for patients with metastatic urothelial cancer shows promise with a 73% response that did not differ for a patient’s PDL1 status.
A cancer survivor doesn’t consider surviving cancer a personal victory, but is grateful for each day.
An Extraordinary Healer essay honoring Nancy Mortlock, RN, OCN, CRNI, CSRN [ Rockwood Clinic in Spokane, Washington ]
Gabriela Hobbs, M.D., discusses how to manage symptoms associated with a myeloproliferative neoplasm diagnosis.
A patient with metastatic breast cancer honors her medical oncologist, Dr. Maria Raquel Nunes, for her calming and optimistic approach.
Breakfast, lunch and dinner options that require minimal prep work and time.
Heidi Gottlieb, a brain tumor survivor and the director and founder of Brain Matters, gives advice to other patients and survivors.
Two weeks in the hospital is no fun, but completely worth it when cancer is caught and treated early.
Our director of patient education, Marty Murphy, discusses his trip for the Moving Mountains for Multiple Myeloma campaign with WRAL.
When I recited my wedding vows to Eli in 1995, I never expected to be his caregiver. At the time, Eli was seemingly at the peak of good health and in the middle of his nine-year career as a professional linebacker.
The 13th annual Rhode Island Cancer Summit will host three keynote speakers who plan to focus on gynecologic cancers and cancer in the LGBTQ community.
Any one of us stricken by cancer remembers our own breaking news.
Kathleen N. Moore, M.D., assistant professor, Stephenson Cancer Center, The University of Oklahoma, discusses developing new PARP inhibitors for patients with ovarian cancer. These new drugs may meaningfully prolong survival from a couple months to potentially years.